MagnetoOrganics Overview
- Founded
-
2007
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
MagnetoOrganics General Information
Description
Developer of fluid biopsy designed to treat cancer. The company's fluid biopsy characterizes circulating tumor cells (CTCs) from a cancer patient's peripheral blood to determine the tissue of origin and to monitor the evolution of the diseases, enabling doctors to diagnose disease at an earlier stage and to make treatment decisions based on the best response to therapy.
Contact Information
Website
www.magnetoorganics.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Primary Office
- 580 Wilderness Peak Drive NorthWest
- Issaquah, WA 98027
- United States
MagnetoOrganics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Dec-2016 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | 01-Jan-2013 | Completed | Generating Revenue |
MagnetoOrganics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Paul Bentley Ph.D | Chief Scientific Officer & Founder | ||
| Bob Snyder Ph.D | Chief Executive Officer & President |